Previous Close | 4.9100 |
Open | 4.9400 |
Bid | 4.4600 x 1000 |
Ask | 5.7700 x 900 |
Day's Range | 4.7600 - 5.2900 |
52 Week Range | 4.2400 - 9.6800 |
Volume | |
Avg. Volume | 15,787 |
Market Cap | 78.956M |
Beta (5Y Monthly) | 1.54 |
PE Ratio (TTM) | 26.12 |
EPS (TTM) | 0.1880 |
Earnings Date | Apr 27, 2022 - May 02, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
NEWARK, N.Y., April 28, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported an operating loss of $0.3 million on revenue of $30.4 million for the first quarter ended March 31, 2022. For the first quarter of 2021, the Company reported operating income of $1.0 million on revenue of $26.0 million. “Strong order flow in commercial end-markets, particularly medical and oil & gas, along with a lift from recently acquired Excell Battery Group (“Excell”), more than offset supply chain
NEWARK, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2022, before the market opens on Thursday, April 28, 2022. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on April 28, 2022. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call